Which painkiller dose works best after kidney stone surgery?
NCT ID NCT07653230
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at two different strengths of the numbing medicine bupivacaine used in a nerve block for pain after kidney stone surgery. Sixty adults having the surgery received either a 0.25% or 0.375% concentration. Researchers measured their pain levels, how much extra pain medicine they needed, and changes in blood inflammation markers. The goal was to see if one concentration provides better pain relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bupivacaine
What this could lead to
If successful, this could help doctors choose the best dose of bupivacaine for pain relief after kidney stone surgery, potentially reducing pain and opioid use.
What could go wrong
This is a small, completed study with only 60 participants. The results may not apply to all patients, and the two concentrations may show little difference in pain control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEPHROLITHIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ankara Training and Research Hospital
Ankara, Mamak, 06420, Turkey (Türkiye)